AzTrials
AzTrials

Hearing Loss, Bilateral or UnilateralNCT06943976

How Parents, Children, and Clinicians Experience Digital Health Tools in Pediatric Audiology

An observational study of Hearing Loss, Bilateral or Unilateral, run by Erasmus Medical Center.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The goal of this observational study is to understand how children with hearing loss, their parents, and health care providers experience digital health questionnaires that are completed before audiology follow-up appointments. Read more about this study

Who is it for?
Ages 7 to 90 yearsHealthy volunteers can take part
Conditions the study is for
Hearing Loss, Bilateral or Unilateral
How many people
80 participants
Where
No sites listed yet
Study dates
1 May 2025to 1 Sep 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Participants will be selected from the population of children and adolescents aged 7 to 18 years with unilateral or bilateral hearing loss who attend the Audiology outpatient clinic of Erasmus MC Sophia Children's Hospital in Rotterdam, the Netherlands. Their parents or primary caregivers will also be invited to participate. Additionally, audiologists and other health care professionals working at the same clinic and using patient-reported outcome measures (PROMs) in routine care will be included in the study.

Who may be able to join

  • Children and adolescents, aged 7-18 years old, with rehabilitated unilateral or bilateral hearing loss, attending the Audiology outpatient clinic of the Erasmus MC Sophia Children's Hospital in Rotterdam, the Netherlands
  • The corresponding parents or caregivers of these pediatric patients
  • Audiologists or other health care providers who systematically use the PROMs during patient interactions at the same Audiology outpatient clinic.

Who cannot join

  • Children or adolescents who are unable to complete the questionnaire, even with support in reading and understanding the items provided by their parents or caregivers.

About this study

Official title: The Value of PROMs in Children With Hearing Loss: Patients', Parents' and Healthcare Professionals' Perspectives

The goal of this observational study is to understand how children with hearing loss, their parents, and health care providers experience digital health questionnaires that are completed before audiology follow-up appointments. The study focuses on children and adolescents (aged 7-18 years old) with hearing loss, and their parents, visiting the Audiology outpatient clinic of the Erasmus MC Sophia Children's Hospital.

The main questions it aims to answer are:

Read more
  • How do parents, children, and clinicians experience digital questionnaires like the HEAR-QL before an audiology visit?
  • Do these digital tools help improve communication and preparation for the appointment?

Participants will:

  • Be invited to complete a short feedback questionnaire about their experience with digital tools
  • Share their views on how helpful or relevant the questionnaires were
  • Health care providers will also give feedback on how they use and interpret the responses in clinical care
Read the detailed description

This observational study evaluates the experiences of children with hearing loss, their parents or caregivers, and audiology health care providers with digital health questionnaires that are completed before pediatric audiology follow-up visits. The study is conducted at the Audiology outpatient clinic of the Erasmus MC Sophia Children's Hospital in Rotterdam, the Netherlands.

As part of routine clinical care, families receive electronic patient-reported outcome measures (PROMs) prior to their appointment, including the Dutch versions of the HEAR-QL questionnaire. These questionnaires are designed to gather insights into the child's hearing-related quality of life and relevant experiences related to hearing care.

Participants in this study include children and adolescents (ages 7-18 years) with unilateral or bilateral hearing loss, their caregivers, and health care professionals (audiologists, speech language pathologists and/or ENT specialists). All participants are invited to provide feedback on the digital questionnaires via brief evaluation surveys (PREMs). This information is collected anonymously and used to understand the usability, relevance, and clinical value of the tools from both the patient and provider perspectives.

Registry-related procedures and quality factors:

  • Quality assurance plan: All data are collected using a secure digital platform. Data entry is automated via survey completion, reducing the risk of manual input errors. Registry procedures follow institutional data management standards.
  • Data checks and validation: Built-in logic and range checks are applied within the digital survey software to prevent incomplete or inconsistent responses.
  • Source data verification: No source data verification is applied, as this study does not use patient medical records beyond the standard demographic and audiological information collected with informed consent.
  • Data dictionary: A standardized variable list is maintained, including definitions, coding schemes, and units of measurement. The HEAR-QL scoring methodology is applied as per published validation guidelines.
  • Standard Operating Procedures (SOPs): SOPs exist for patient approach, informed consent, survey distribution, data storage, and privacy protection. All procedures align with institutional review board approvals.
  • Sample size: The study aims to include a minimum of 50 families (about 80 respondents) over a 4-month period, which is sufficient for descriptive and exploratory analyses of user experience outcomes.
  • Missing data: Missing data is not expected, as all questions in the digital questionnaires are required fields. The system prevents submission of incomplete surveys. Therefore, no item-level missingness or imputation procedures are applicable.
  • Statistical analysis plan: Quantitative survey responses will be summarized using descriptive statistics (e.g., means, medians, proportions). Associations between user experience scores and patient characteristics (e.g., age, hearing device type) may be explored using nonparametric tests or regression analyses as appropriate. Qualitative comments from participants will be grouped thematically.

This study aims to contribute to the growing body of knowledge on patient and provider experiences with digital health tools in pediatric audiology. Results may inform future implementation and optimization of PROMs in routine hearing care.

Keywords
Hearing Loss, Quality of Life, PROMs, PREMs, Children, Digital Health Care
Medical subject headings
Hearing Loss

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Experience with digital health questionnaires

    Experience scores from a custom feedback survey completed by parents/caregivers and children aged 7-18 years, evaluating clarity, relevance, and burden of digital questionnaires.

    Measured: Within 3 months after the audiology appointment

Secondary outcomes (1)
  1. Clinician-perceived utility of digital questionnaires

    Ratings from audiology/health care staff on the usefulness of digital patient-reported outcome measures (PROMs) in preparing for or guiding the consultation.

    Measured: Within the time frame of the patient enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2025
  2. Study start1 May 2025 (estimated)
  3. Primary completion1 Aug 2025 (estimated)
  4. Study completion1 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06943976
Sponsor's protocol ID
13562
Status last verified
Apr 2025
First submitted
17 Apr 2025
Last updated
25 Apr 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hearing Loss, Bilateral or Unilateral, run by Erasmus Medical Center.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 25 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Experience with digital health questionnaires (time frame: Within 3 months after the audiology appointment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in